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ABSTRACT
Objectives: To analyse the relationships between
chronic conditions, body functions, activity limitations
and participation restrictions in the International
Classification of Functioning, Disability and Health (ICF)
framework.
Design: A cross-sectional study.
Setting: 2 geographical areas in the Autonomous
Region of Aragon, Spain, namely, a rural area, Cinco
Villas, and an urban area in the city of Zaragoza.
Participants: 864 individuals selected by simple
random sampling from the register of Social Security
card holders, aged 50 years and over, positive to
disability screening.
Main outcome measures: ICF Checklist—body
function domains, WHO Disability Assessment
Schedule 2.0 (WHODAS 2.0, 36-item (WHODAS-36))
global scores and medical diagnoses (chronic
conditions) from primary care records.
Results: Mild disability (WHODAS-36 level 5–24%)
was present in 51.5% of the sample. In the adjusted
ordinal regression model with WHODAS-36 as the
dependent variable, disability was substantially
associated with moderate-to-complete impairment in
the following functions: mental, OR 212.8 (95% CI 72
to 628.9); neuromusculoskeletal, OR 44.8 (24.2 to
82.8); and sensory and pain, OR 6.3 (3.5 to 11.2). In
the relationship between health conditions and body
function impairments, the strongest links were seen
for: dementia with mental functions, OR 50.6 (25.1 to
102.1); cerebrovascular disease with
neuromusculoskeletal function, OR 5.8 (3.5 to 9.7);
and chronic renal failure with sensory function and
pain, OR 3.0 (1.49 to 6.4). Dementia, OR 8.1 (4.4 to
14.7) and cerebrovascular disease, OR 4.1 (2.7 to 6.4)
were associated with WHODAS-36 scores.
Conclusions: Body functions are heterogeneously
linked to limitations in activities and restrictions on
participation, with the highest impact being due to mental
and musculoskeletal functions. This may be relevant for
disability assessment and intervention design, particularly
if defined on a body function basis. Control of specific
health conditions, such as dementia and cerebrovascular
disease, appears to be paramount in reducing disability
among persons aged 50 years and over.
INTRODUCTION
The consequences of chronic disorders in
older age include adverse health outcomes,
such as disability, dependence and mortality,
increased use of health and social services,
high drug use and poor quality of life.1–4
Policies for reducing disability caused by
chronic disorders encompass disease preven-
tion strategies, rehabilitation and support
focused on function recovery, compensatory
measures and comprehensive care manage-
ment.5 Yet priorities as regards which func-
tion domains should be preferentially
targeted due to their higher impact on activity
limitations and restrictions on participation
(ALRP) still remain unclear.
Strengths and limitations of this study
▪ International Classification of Functioning,
Disability and Health (ICF) framework approach.
▪ Population-based view.
▪ Supported by primary care diagnostic data from
a national health system with high coverage.
▪ Small non-disabled group that screened positive
for disability.
▪ Non-validated checklist scores and diagnoses
established by health professionals.
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The International Classification of Functioning,
Disability and Health (ICF) is the WHO framework for
measuring health and disability at both the individual and
population levels.6 7 The ICF was designed to be an exten-
sive and universally accepted instrument for comprehen-
sively describing and categorising patients’ functioning
and disability in a systematic and standardised way. In the
ICF, disability is conceptualised as a deficit in any of its
three constituent domains (body functions and structure,
activities and participation), and the negative result of the
‘dynamic interaction between a person’s health condition,
environmental factors and personal factors’.8 Disability
may be due to a health condition that gives rise to impair-
ment in body functions and structure and ALRP. The fol-
lowing two instruments have been developed to
implement the ICF: the ICF Checklist, a version of the ICF
for clinical practice;6 9 and the WHO Disability Assessment
Schedule 2.0 (WHODAS 2.0), a standardised cross-cultural
measurement of disability.10 Despite such developments,
there is a need to consider the interaction between ICF
components. An initial approach might assume that pre-
dominant effect directions acted from health conditions
to reduction in body functions and that a proportion of
ALRP was determined by low functional level. For
instance, Alzheimer’s disease reduces memory, and poor
memory may limit compliance with pharmacological
therapy. Bidirectional effects can be assumed to be
present, for example, where muscle power in a limb that is
initially unaffected by stroke is lost as a consequence of low
physical activity. An initial approach might thus assume
potentially predominant effects and non-instrumental,
clinical assessment of body functions.
Previous studies have shown the usefulness of the ICF
system and its instruments, the ICF Checklist and
WHODAS 2.0, in different health conditions, such as
spinal cord injury or lymphoedema,11 12 populations,
such as children or elders,13 14 and settings, such as
rehabilitation, geriatric care or research.15–18
Accordingly, the aim of this study was to examine the
role of body functions in the relationship between
chronic health conditions and ALRP, among people
screened for disability in a Spanish population.
METHODS
Study design and population sample
This study used cross-sectional data drawn from a survey
conducted from 2008 to 2011. The participants were
sampled from the register of Social Security card
holders aged 50 years or over and living in the following
two geographical areas of the Autonomous Region of
Aragon (Spain): a rural area, Cinco Villas, a district
made up of 48 municipalities in the province of
Zaragoza;19 and an urban area, two health districts, in
the city of Zaragoza. The study methods and results of
the screening procedure have been described in detail
for the Cinco Villas, rural area survey.19 Methods were
replicated when studying the urban area.
Participant selection: We initially selected 2000 partici-
pants from Cinco Villas and 856 from the city of
Zaragoza by simple random sampling. From this sample,
some individuals were then excluded for any of the fol-
lowing reasons: (1) the participant was not a resident in
the study area (317 from Cinco Villas, 15 from
Zaragoza); (2) the participant could not be located (222
from Cinco Villas, 5 from Zaragoza); (3) the participant
had died (101 from Cinco Villas, 1 from Zaragoza) and
(4) the participant refused to participate or was unable
to schedule or keep the appointment for evaluation pur-
poses (110 from Cinco Villas, 330 from Zaragoza). From
the Cinco Villas sampling area, 48 participants were
additionally excluded due to lack of sufficient data,
leaving a study sample of 1707 individuals with compre-
hensive assessments, 1202 from Cinco Villas and 505
from Zaragoza. All participants, or their relatives in
selected cases, signed the informed consent form before
taking part in the study.
Patient involvement: There was no patient involvement
in this study other than that required for disability assess-
ment during visits to homes or institutions. In order to
preserve a neutral position regarding any potential offi-
cial benefits of the assessments, the purpose-trained
team (a physiotherapist and psychologist, 2 occupational
therapists, a public health veterinarian and a physical
medicine and rehabilitation specialist) made it clear that
they were acting independently and were not answerable
to the social service authorities.
Assessments
Screening
Data were collected in two stages, in accordance with a
screening scheme. The WHODAS 2.0, a
non-disease-specific tool for assessment of disability, was
deemed suitable due to the considerably high number
of diagnoses involved in epidemiological and non-
clinical studies. Data on sociodemographic characteris-
tics (sex, age, marital status, living arrangements and
education) and cognitive status were collected for the
entire sample, and individuals were screened using the
WHODAS 12-item, a shortened version of the disability
assessment tool recommended by the WHO for epide-
miological studies, that is, WHODAS 2.0, 36-item
(WHODAS-36).10 The threshold for screening positive
using the 12-item version was at least one positive answer
(see online supplementary material, appendix A). The
Mini-Examen Cognoscitivo (MEC),20 the Spanish version of
the Mini-Mental Status Examination (MMSE), was used
for assessing cognitive status. Participants with a value of
MEC<24 (range 0–35 points) were also deemed to be
positive to screening and underwent full assessment.
Full assessment
Participants who screened positive for disability under-
went assessment using a protocol focused on primary
care diagnoses, disability, lifestyle, and use of health and
social resources. Information on diagnoses was obtained
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mainly from medical records in primary care, reports by
health professionals and, in a few cases, proxy reports or
self-reports, creating a list of 26 prevalent and relevant
chronic conditions in older people (see Results).
Depressive symptomatology was defined as a score of 4
or higher (the standard cut-off point) on the EURO-D
scale, a 12-item scale that assesses symptoms of depres-
sion and was developed in an 11-country, Europe-wide
collaboration which included Spain,21 and was then
further validated for an elderly Spanish population.22 As
with other similar scales, the EURO-D is likely to be
unreliable in cognitively impaired individuals; hence,
participants with an MEC score <15 were assigned a
missing value on the EURO-D. An algorithm, based on
applying Diagnostic and Statistical Manual of Mental
Disorders, Fourth Edition (DSM-IV) criteria to EURO-D
scores,21 22 was used to identify major depression on the
date of visit.23
The ICF Checklist9 is a semistructured guide designed
to help trained personnel record data on major ICF
categories (body functions and structures, activities and
participation), after examining clinical information. For
the purposes of this study, only body function (codes
b1–b8) and qualifiers (extent of impairment, with scores
ranging from 0—no impairment, to 1—mild, 2—moder-
ate, 3—severe and 4—complete impairment) were used
(see online supplementary material, appendix B).
Global scores for each function (eg, b1—mental) were
obtained by averaging component scores (eg, b110–
b167), and assigned a discrete value by rounding (stan-
dard rules) the resulting mean. The procedure implies
that any given item’s potential contribution to a domain
is the same. The ICF Checklist qualifier scale ratings of 8
and 9 were treated as missing values and the item
dropped from denominator to calculate averages.
ALRP (see prevalence reported for Cinco Villas)24 was
evaluated with the WHODAS-36,10 a questionnaire that
assesses difficulties in six domains, that is, understanding
and communication, getting around, self-care, getting
along with people, life activities and participation in
society. Items are answered on a five-point Likert-type
scale, ranging from 0 (no difficulty) to 4 (extreme diffi-
culty) (see online supplementary material, appendix C).
Global scores were calculated using the WHO Spanish
Official Group scoring rules,25 and categorised as 1—no
problem (0–4%), 2—mild (5–24%), 3—moderate (25–
49%), 4—severe (50–95%) and 5—extreme/complete
problem (95–100%). Given the low proportion of indivi-
duals presenting with extreme/complete WHODAS-36
disability, 0.1% in this study, the latter two categories
were collapsed into a single one (4—severe and
extreme/complete).
Design of analysis and modelling approaches
The analytical strategy was based on the ICF framework,
and its well-known scheme is depicted in black bidirec-
tional arrows and labels (figure 1). We adopted a three-
format procedure (red unidirectional arrows in figure 1)
representing three groups of associations in which esti-
mates for three dependent variables were computed by
means of ordinal logistic regression, using proportional
odds models. The ORs computed from these models
represent the odds of being above a particular category
of the dependent variable versus coming within or falling
below that category.26 Three group models, denoted as A,
B and C, were fitted and presented as a two-stage analysis.
The first analysis (A models) designed to quantify the
relationship of body functions with activities and
participation establishes which body functions would con-
stitute the main focus of attention in the second stage.
The second stage explores, on the one hand, the associa-
tions between health conditions and body functions (B
models) and, on the other, those between health condi-
tions and activities/participation (C models), presenting
the results in one table. In the group A models, the main
independent variables were the eight ICF Checklist body
function scores categorised into three groups (score 0:
no impairment; 1: mild impairment; and 2–4:
moderate-to-complete impairment), and the dependent
variable was the WHODAS-36 variable scored from 1 to
4. In the group B and C models, the independent vari-
ables were the 26 health conditions, with the dependent
variable being as follows: in group B, each of the b1-b8
body function variables; and in group C, the overall
WHODAS-36 variable used in group A models (activity/
participation in figure 1). Adjusted models included age,
sex, years of education, sampling area (Cinco Villas/
Zaragoza) and residential status (own home/institution)
but no other health conditions or body function
domains.
RESULTS
Of the 1707 valid participants, 864 (635 from Cinco
Villas, 229 from Zaragoza) who tested positive to
Figure 1 Model of disability that is the basis for the
International Classification of Functioning, Disability and
Health (ICF) framework, depicted in black bidirectional arrows
and labels. Red arrows (not a part of the ICF framework)
represent associations tested in the three main analytical
approaches in the study.
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screening formed the final sample, 65.2% women, mean
age 73.2 (SD 11.4) years. Table 1 shows the sample’s main
sociodemographic characteristics: approximately 1/3 was
urban and only 12.7% had an educational level higher
than primary. Compared with the total survey population,
as shown in the first column of table 1, participants who
screened positive were older, and the proportion shown
by the test to be cognitively impaired almost doubled.
The distribution of the sample by ICF body function
impairment category and disability level and the associa-
tion between body functions and WHODAS-36 values
(group A models) are shown in table 2. While
moderate-to-complete impairment was present in
varying proportions, it was particularly high for genitour-
inary and reproductive functions (48.6%), with simi-
lar data by sex. The lowest percentages of
moderate-to-complete impairment were observed for the
cardiovascular, haematological, immunological and
respiratory systems (2.4%), and voice and speech
(4.5%). In terms of disability (WHODAS-36), half the
sample (51.5%) had mild disability, 28.9% had moderate
disability, and 16.1% had severe/extreme disability.
Women registered a higher proportion of severe/com-
plete disability (18.6%) than did men (11.4%) (table 2).
Relationships between body function and
WHODAS-36 values are shown in the right-hand column
of table 2. Mental, neuromusculoskeletal, and sensory
and pain functions displayed the strongest links in the
adjusted model. ALRP were associated with both mild
impairment (OR 6.4) and moderate/complete impair-
ment (OR 212.8) in mental functions. Mild (OR 4.4)
and moderate-to-complete impairment (OR 44.8) in
neuromusculoskeletal functions was likewise clearly asso-
ciated with ALRP. Dose–response effects were suggested.
Online supplementary table S1 shows associations
between the 31 body function subcategories and
WHODAS-36 values. Strong associations were seen in
the case of mental functions for orientation (b114) and
intellectual (b117) functions (OR 22.7 and OR 17.88,
respectively), and in the case of neuromusculoskeletal
and movement-related functions for muscle tone (b775)
and muscle power (b770) (OR 9.27 and OR 10.93,
respectively).
The prevalence of relevant chronic conditions and
their specific links to selected body functions (b1, b7
and b2, given the results from table 2) and ALRP
(WHODAS-36), group A and C models, respectively, are
shown in table 3. Arthritis/osteoarthritis (49%) and
hypertension (46%) were the most frequent diseases
overall. Major depression, according to the aforemen-
tioned algorithm, was detected in 3% of the sample.
In the adjusted model, dementia (OR 50.6) and severe
mental disorders (OR 15.2) displayed the strongest
associations with mental function impairment.
Table 1 General characteristics of the study sample: values shown as numbers (percentages)
Screened positive
All 1707 (100) Total 864 (100) Men Women
Sex
Men 740 (43.4) 301 (34.8)
Women 967 (56.6) 563 (65.2)
Age group (years)
50–64 670 (39.3) 215 (24.9) 76 (25.4) 139 (24.7)
65–79 689 (40.4) 360 (41.8) 131 (43.8) 229 (40.7)
≥80 346 (20.3) 287 (33.3) 92 (30.8) 195 (34.6)
Residential status
Own home 1633 (95.7) 799 (92.5) 274 (91.0) 525 (93.3)
Institutionalised 74 (4.3) 65 (7.5) 27 (9.0) 38 (6.7)
Sampling area
Cinco Villas (rural) 1202 (70.4) 635 (73.5) 235 (78.1) 400 (71.0)
Zaragoza (urban) 505 (29.6) 229 (26.5) 66 (21.9) 163 (29.0)
Highest academic qualification
Lower than primary 607 (35.6) 388 (45.1) 146 (48.5) 242 (43.2)
Primary 736 (43.2) 364 (42.3) 106 (35.2) 258 (46.1)
Secondary and higher 360 (21.1) 109 (12.7) 49 (16.3) 60 (10.7)
Marital status
Married or lives with partner 1135 (66.6) 502 (58.2) 199 (66.1) 303 (53.9)
Divorced or separated 33 (1.9) 16 (1.9) 7 (2.3) 9 (1.6)
Single 189 (11.1) 90 (10.4) 46 (15.3) 44 (7.8)
Widow/widower 346 (20.3) 255 (29.5) 49 (16.3) 9 (36.7)
Cognitive impairment (MEC<24)
No 1514 (90.1) 684 (80.5) 241 (82.0) 443 (79.7)
Yes 166 (9.9) 166 (19.5) 53 (18.0) 113 (20.3)
MEC, Mini-Examen Cognoscitivo (Spanish version of the Mini-Mental Status Examination (MMSE)).
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Neurodegenerative diseases and dystrophies (OR 11.8),
cerebrovascular diseases (OR 5.8) and dementia (OR
3.7) were associated with neuromusculoskeletal func-
tions. Chronic renal failure (OR 3.0) and auditive
impairment (OR 2.8) were related to sensory and pain
functions. From the group C models, it will be seen that
dementia (OR 8.1) and cerebrovascular disease (OR
4.1) were associated with ALRP (WHODAS-36).
Online supplementary table S2 shows associations
between health conditions and the remaining body
functions (b3, b4, b5, b6 and b8) in the group A
models. Particularly strong associations were seen
between cardiac arrhythmia, (OR 11.24) heart failure
(OR 12.53) and asthma (OR 7.44) and cardiovascular,
haematological and respiratory system functions, and
between urinary incontinence (OR 8.00) and genitour-
inary and reproductive functions.
DISCUSSION
This study is the first to provide non-clinical data on the
relationship between body functions and ALRP within
the ICF framework. The role of health conditions in
ALRP has been described in detail for Cinco Villas,24
with results that were quite similar in magnitude to those
reported here for group C models. Our health condition
Table 2 Distribution of the ICF Checklist body function and WHODAS-36 scores in the study sample, overall and by sex,
and association between the ICF Checklist body function domains and disability measured by the WHODAS-36 scale
Total* Men* Women* Crude OR† Adjusted OR† (95% CI)
b1: Mental
No impairment 533 (62.1) 190 (63.8) 343 (61.3) 1 (ref.) 1 (ref.)
Mild impairment 262 (30.5) 92 (30.9) 170 (30.4) 7.46 6.39 (4.59 to 8.89)
Moderate-to-complete impairment 63 (7.3) 16 (5.4) 47 (8.4) 364.17 212.8 (72.0 to 628.9)
b2: Sensory and pain
No impairment 95 (11.1) 44 (14.8) 51 (9.1) 1 (ref.) 1 (ref.)
Mild impairment 597 (69.7) 215 (72.4) 382 (68.2) 2.04 1.83 (1.11 to 3.01)
Moderate-to-complete impairment 165 (19.3) 38 (12.8) 127 (22.7) 9.70 6.30 (3.54 to 11.2)
b3: Voice and speech
No impairment 770 (90.8) 263 (89.2) 507 (91.7) 1 (ref.) 1 (ref.)
Mild impairment 40 (4.7) 18 (6.1) 22 (4.0) 2.72 2.62 (1.42 to 4.87)
Moderate-to-complete impairment 38 (4.5) 14 (4.7) 24 (4.3) 7.10 5.46 (2.66 to 11.2)
b4: Cardiovascular, haematological, immunological and respiratory systems
No impairment 545 (63.5) 183 (61.4) 362 (64.6) 1 (ref.) 1 (ref.)
Mild impairment 292 (34.0) 106 (35.6) 186 (33.2) 1.70 1.44 (1.08 to 1.91)
Moderate-to-complete impairment 21 (2.4) 9 (3.0) 12 (2.1) 7.52 4.83 (1.90 to 12.3)
b5: Digestive, metabolic and endocrine systems
No impairment 338 (39.4) 144 (48.3) 194 (34.6) 1 (ref.) 1 (ref.)
Mild impairment 479 (55.8) 142 (47.7) 337 (60.2) 1.5 1.50 (1.12 to 2.01)
Moderate-to-complete impairment 41 (4.8) 12 (4.0) 29 (5.2) 3.08 4.10 (2.15 to 7.8)
b6: Genitourinary and reproductive
No impairment 259 (30.3) 92 (30.9) 167 (29.9) 1 (ref.) 1 (ref.)
Mild impairment 181 (21.1) 56 (18.8) 125 (22.4) 1.15 0.95 (0.63 to 1.43)
Moderate-to-complete impairment 416 (48.6) 150 (50.3) 266 (47.7) 4.69 3.40 (2.40 to 4.83)
b7: Neuromusculoskeletal and movement related
No impairment 259 (30.2) 108 (36.2) 151 (27.0) 1 (ref.) 1 (ref.)
Mild impairment 511 (59.6) 157 (52.7) 354 (63.2) 5.01 4.40 (3.03 to 6.38)
Moderate-to-complete impairment 88 (10.3) 33 (11.1) 55 (9.8) 58.36 44.8 (24.2 to 82.8)
b8: Skin and related structures
No impairment 695 (82.3) 244 (83.3) 451 (81.9) 1 (ref.) 1 (ref.)
Mild impairment 88 (10.4) 29 (9.9) 59 (10.7) 1.41 1.34 (0.86 to 2.10)
Moderate-to-complete impairment 61 (7.2) 20 (6.8) 41 (7.4) 4.31 3.10 (1.75 to 5.47)
WHODAS-36
No disability 30 (3.5) 13 (4.4) 17 (3.0) − −
Mild disability 441 (51.5) 164 (55.0) 277 (49.6) − −
Moderate disability 247 (28.9) 87 (29.2) 160 (28.7) − −
Severe-to-complete disability 138 (16.1) 34 (11.4) 277 (18.6) − −
ORs from group A models in figure 1.
*Values shown as numbers (percentages).
†Unadjusted and adjusted ORs from ordinal logistic regression models with categorised WHODAS-36 scores (values 1–4) as the dependent
variable. Adjusted models included age, sex, years of education, sampling area (Cinco Villas/Zaragoza) and residential status (own home/
institution).
ICF, International Classification of Functioning, Disability and Health; WHODAS-36, WHO Disability Assessment Schedule 2.0, 36-item.
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Table 3 Association between diseases and mental, neuromusculoskeletal and sensory ICF Checklist body functions, and disability level as measured by the
WHODAS-36 scale
b1: Mental
b7: Neuromusculoskeletal
and movement related b2: Sensory and pain WHODAS-36
Health condition (prevalence, %)
Crude
OR*
Adjusted OR*
(95% CI)
Crude
OR*
Adjusted OR*
(95% CI)
Crude
OR*
Adjusted OR*
(95% CI)
Crude
OR†
Adjusted OR†
(95% CI)
Hypertension (46) 0.69 0.51 (0.37 to 0.69) 1.24 1.00 (0.75 to 1.33) 1.36 1.16 (0.85 to 1.58) 0.98 0.77 (0.59 to 1.02)
Ischaemic heart disease (9) 1.28 1.03 (0.62 to 1.73) 1.19 0.90 (0.53 to 1.51) 0.88 0.81 (0.46 to 1.42) 1.37 1.01 (0.62 to 1.64)
Arrhythmias (13) 1.21 0.91 (0.59 to 1.41) 1.78 1.17 (0.75 to 1.82) 1.87 1.55 (0.98 to 2.45) 1.85 1.40 (0.94 to 2.10)
Heart failure (3) 2.38 1.80 (0.86 to 3.77) 2.04 1.60 (0.75 to 3.41) 3.40 2.62 (1.19 to 5.76) 2.31 1.66 (0.83 to 3.29)
Cerebrovascular disease (11) 4.60 4.30 (2.76 to 6.71) 6.38 5.82 (3.50 to 9.67) 1.29 0.96 (0.59 to 1.58) 4.35 4.13 (2.67 to 6.39)
Peripheral arterial disease (2) 1.83 2.02 (0.76 to 5.38) 0.99 0.73 (0.25 to 2.16) 1.56 2.25 (0.72 to 7.02) 1.36 1.57 (0.57 to 4.29)
COPD (8) 1.71 1.32 (0.79 to 2.22) 1.11 0.81 (0.47 to 1.39) 1.04 0.89 (0.51 to 1.58) 1.32 1.09 (0.67 to 1.80)
Asthma (3) 2.05 2.10 (0.97 to 4.58) 2.21 2.05 (0.93 to 4.49) 1.93 1.69 (0.75 to 3.85) 1.71 1.45 (0.68 to 3.11)
Chronic renal failure (4) 1.95 1.65 (0.82 to 3.32) 2.18 1.91 (0.90 to 4.08) 3.27 2.99 (1.39 to 6.44) 3.52 2.86 (1.45 to 5.64)
Diabetes (17) 1.23 1.18 (0.80 to 1.73) 1.60 1.38 (0.95 to 2.02) 1.31 1.43 (0.95 to 2.13) 1.83 1.89 (1.33 to 2.68)
Thyroid dysfunctions (9) 0.70 0.71 (0.41 to 1.23) 0.77 0.74 (0.45 to 1.20) 1.44 1.32 (0.78 to 2.21) 0.86 0.79 (0.48 to 1.29)
Chronic liver diseases (1) 1.68 2.72 (0.67 to11.09) 0.50 0.86 (0.20 to 3.82) 1.30 1.95 (0.36 to 10.46) 1.14 2.03 (0.52 to 7.88)
Anaemia (4) 1.48 1.39 (0.70 to 2.75) 0.89 0.81 (0.41 to 1.61) 1.63 1.71 (0.84 to 3.46) 1.00 0.79 (0.42 to 1.48)
Cancer (6) 1.37 1.35 (0.73 to 2.50) 1.05 1.23 (0.66 to 2.28) 0.98 1.36 (0.70 to 2.63) 1.09 1.27 (0.72 to 2.25)
Dementia (7) 71.40 50.58 (25.1 to 102.1) 5.91 3.66 (1.98 to 6.77) 1.17 0.58 (0.30 to 1.13) 13.29 8.09 (4.44 to 14.73)
Neurodegenerative diseases and
dystrophies (3)
2.34 1.93 (0.83 to 4.47) 9.01 11.76 (5.02 to 27.6) 1.22 2.19 (0.88 to 5.44) 3.46 3.12 (1.39 to 7.02)
Severe mental disease (2) 11.35 15.17 (5.31 to 43.35) 0.96 1.49 (0.44 to 5.09) 0.28 0.33 (0.09 to 1.18) 3.68 3.54 (1.13 to 11.06)
Depression history (18) 2.04 2.2 (1.52 to 3.16) 1.34 1.26 (0.87 to 1.83) 1.41 1.23 (0.82 to 1.83) 1.89 1.99 (1.40 to 2.82)
Depressive symptoms (EURO-≥4) (31) 3.89 5.17 (3.57 to 7.49) 1.41 1.30 (0.93 to 1.83) 1.73 1.70 (1.18 to 2.45) 2.49 2.99 (2.15 to 4.14)
Major depression (3) 2.45 3.51 (1.59 to 7.74) 1.11 1.21 (0.54 to 2.74) 1.72 2.35 (0.98 to 5.63) 2.33 3.09 (1.41 to 6.77)
Anxiety disorder (9) 0.99 1.22 (0.73 to 2.05) 0.56 0.56 (0.34 to 0.92) 0.52 0.49 (0.28 to 0.85) 0.78 0.86 (0.54 to 1.39)
Arthritis/osteoarthritis (49) 0.91 0.71 (0.52 to 0.96) 1.99 1.63 (1.22 to 2.18) 2.17 1.85 (1.34 to 2.54) 0.96 0.75 (0.57 to 0.99)
Hip fracture (2) 2.75 1.19 (0.44 to 3.19) 3.38 2.25 (0.80 to 6.27) 1.99 1.15 (0.40 to 3.33) 5.16 2.28 (0.91 to 5.67)
Vision impairment (7) 1.50 1.23 (0.68 to 2.21) 0.79 0.74 (0.41 to 1.35) 1.86 1.17 (0.63 to 2.14) 1.55 1.17 (0.67 to 2.06)
Audition impairment (4) 1.50 1.07 (0.52 to 2.23) 1.25 1.08 (0.53 to 2.17) 3.67 2.79 (1.36 to 5.70) 1.75 1.29 (0.65 to 2.53)
Urinary incontinence (6) 3.61 2.64 (1.47 to 4.73) 2.52 1.51 (0.82 to 2.78) 1.28 0.83 (0.43 to 1.60) 2.81 1.80 (1.02 to 3.18)
*ORs obtained from an ordinal logistic model with body function scores as the dependent variable. Adjusted models included age, sex, years of education, sampling area (Cinco Villas/
Zaragoza) and residential status (own home/institution).
†ORs obtained from an ordinal logistic model with categorised WHODAS-36 scores (values 1–4) as the dependent variable. Adjusted models included age and sex.
COPD, chronic obstructive pulmonary disease; ICF, International Classification of Functioning, Disability and Health; WHODAS-36, WHO Disability Assessment Schedule 2.0, 36-item.
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approach to ALRP is thus subordinated to relevant find-
ings in the body function analysis. The study essentially
shows that mental, neuromusculoskeletal and sensory
and pain functions are strongly related to ALRP, and that
dementia, severe mental disorders, neurodegenerative
diseases, cerebrovascular diseases, chronic kidney failure
and hearing loss are the conditions having the strongest
links to at least one of the above three body functions.
Heart diseases were paramount for other functions. In
addition to its methodological, door-to-door and analyti-
cally innovative approach, the strengths of this study are:
(1) application of disability assessments by trained per-
sonnel; (2) almost complete coverage of diagnostic data
and (3) the broad geographical, occupational and resi-
dential (urban and rural) profile of the sample. These
features confer unique properties on the survey, as com-
pared with traditional door-to-door surveys conducted on
small, fairly homogeneous populations and to national
disability surveys which rely, at least in the case of Spain,
on interviews and self-reported or proxy-reported data.17
Limitations of the study
Losses between the sampled and participating popula-
tions reported for the Cinco Villas sample in detail,
10.6%,19 were modest because the census, officially con-
ducted at 10-year intervals, was updated during the
field work, a frequent procedure in door-to-door
surveys. Other limitations are due to the failure to study
physical environmental factors (lower part of the
chart), despite the fact that these might have an impact
on WHODAS 2.0 assessments.27 28 Contextual factors,
such as family relationships or walking aids, which have
been found to be moderators for the association
between body functions and ALRP, were ignored in our
present approach.29 Analysis of the effects of variables
included in the ICF Body Structures chapter was
rejected, due to the high frequency of multimorbidity
at advanced ages and collinearity with body functions.
The proportion of participants diagnosed with specific
health conditions among those who screened negative
for disability might be lower than that seen among
those with lowest WHODAS-36 scores (0–5%), perhaps
inducing OR underestimates. Finally, the Checklist’s psy-
chometric properties, for example, reliability, are not
well established. However, we sought to overcome this
drawback by giving raters intensive training designed to
ensure inter-rater reliability, as recommended by
Okochi et al.15 Despite the lack of information on the
metric attributes of the ICF Checklist, it has been
extensively used in several settings,30 something that
might well support its usefulness. Such limitations, par-
ticularly if linked to contextual factors, may affect the
external validity of findings. The use of other analytical
approaches, such as longitudinal design or structural
equation modelling, in future studies would allow for
underlying questions of mediation/moderation and
causality to be addressed.
Body function and ALRP
The magnitude of ALRP ORs for moderate-to-complete
loss of function in mental, neuromuscular and
movement-related functions, and the high proportion of
moderate-to-complete loss of mental and neuromuscu-
loskeletal functions (7.3% and 10.2%, respectively in
table 2) indicate the relevance of such functions among
the middle-aged and elderly in terms of global
WHODAS 2.0 scores. A similar line of reasoning may be
applied when it comes to explaining the higher ORs for
dementia, cerebrovascular disease and severe mental dis-
orders, which are relatively infrequent conditions in
comparison with highly prevalent, albeit less disabling,
conditions, such as diabetes and hypertension. The rele-
vance of sensory loss and pain in patients with chronic
renal failure might reflect the well-known weight of dia-
betes mellitus among this subpopulation and illustrates
the potential role of comorbidity.31 32 In sum, functions
with the highest impact on WHODAS 2.0 scores (mental
and musculoskeletal functions) may have to be pre-
served, so that functioning across the life course can be
optimised. Public health strategies to prevent health con-
ditions may benefit from definition on a body function
basis, that is, approached from lifestyle or behavioural
interventions.
Health conditions and body function
Our results point to the relevance of mental disorders
among the middle-aged and elderly. The International
Classification of Diseases, 10th Revision (ICD-10) head
on mental disorders encompasses a heterogeneous and
wide spectrum, in which dementia and depression are
classified as major causes of disability. Experts include
multiple sclerosis and neurodegenerative diseases, such
as Parkinson’s disease, in which an increasingly clinical
component of non-motor symptoms is recognised. The
WHO recently stressed the importance of mental health
by designing a global plan.33 Experts are of the view that
prevention of mental disorders, rather than being
primary, is now mainly secondary, tertiary or selected,
due to the lack of knowledge of established causes for
many mental disorders.34 Preventing mental function
decline might require targeted designs including primary
and secondary prevention in a life course perspective.
In a different study using WHODAS 2.0 on a Spanish
population of >74-year-olds, mental (psychiatric condi-
tions and dementia) and neurological disorders and
stroke accounted for 59.76% and 20.21% of severe/
extreme disability status, respectively, and the conditions
making the highest contribution to severe/complete dis-
ability status were Alzheimer’s disease and depression,
with aetiological fractions of 31.42% and 18.62%, respec-
tively.35 It seems that our study has detected associations
which are particularly present in old age. Longitudinal
studies of ICF mental and neuromusculoskeletal func-
tion change with age may help to verify our study find-
ings and define the optimal age for public health
intervention.
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The study shows that frequent ailments, such as arthri-
tis/osteoarthritis, hypertension and thyroid dysfunction,
generate a limited loss of function and ALRP. This
pattern has been seen in large surveys, such as those con-
ducted in Australia, where many conditions which
headed the list in terms of frequency were ranked
towards the bottom in terms of the likelihood of being
associated with a severe or profound core activity restric-
tion.36 These included asthma, hypertension, back pro-
blems, arthritis and hearing loss. Our results also show
the opposite pattern, that is, low frequency and high
ALRP impact, for neurodegenerative disease and severe
mental disease. On the other hand, frequent ailments
with a high impact on risk of ALRP were observed for
stroke and dementia, a similar pattern to that seen for
over 65-year-olds in Australia, where 96% of people with
dementia had a severe or profound core activity restric-
tion, followed by schizophrenia (93%), speech problems
(90%) and Parkinson’s disease (82%). The relationship
between diagnosis, function and participation has also
been described in other samples, such as children with
physical disabilities or special care needs,37 38 older
adults39 and people with specific chronic conditions.40 41
Implications of results for an individual global disability
measure
The need for a global measure of disability has been
stressed by Madden et al.42 Our results would point to
potential discordances between ICF score measure-
ments for specific functions and those for ALRP.
Diagnoses having the highest impact on loss of mental/
cognitive and movement-related functions might gener-
ate high impairment and ALRP scores as compared
with diagnoses severely affecting other functions, that
is, voice and speech, or functions of the digestive, meta-
bolic and endocrine systems. The functional impair-
ment assessment methodology suggested by the
American Medical Association guides,43 based on
impairment selection determined by expected relevance
in activities of daily life, as proposed for Spanish pro-
grammes, might go some way towards circumventing
such problems.
CONCLUSIONS
This study furnishes evidence on the heterogeneous
relationship between health conditions, body functions
and ALRP within the ICF framework. The results under-
score how specific diagnoses often translate into mental
and neuromuscular impairments and these, in turn,
contribute to lower activity and participation levels.
These findings may have important implications for dis-
ability assessment, and the design of rehabilitation pro-
grammes and preventive measures in the community.
Public health strategies may benefit from definition on a
body function basis, that is, approached from lifestyle or
behavioural interventions.
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